Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Kathleen M. Dungan MD, MPH Advisory Board

Deborah J. Wexler MD, MSc Associate Editor

Silvio E. Inzucchi MD Editor-in-Chief

See All Experts

featured

Published in Diabetes and

Journal Scan / Research · March 12, 2020

Association of Lifestyle Intervention, Fitness, and BMI With Heart Failure in Overweight Adults With Type 2 Diabetes

Circulation

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Paul Thompson MD

Circulation

Association of Intensive Lifestyle Intervention, Fitness and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial

Circulation 2020 Mar 05;[EPub Ahead of Print], A Pandey, KV Patel, JL Bahnson, SA Gaussoin, CK Martin, A Balasubramanyam, KC Johnson, DK McGuire, AG Bertoni, D Kitzman, JD Berry

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Association of Lifestyle Intervention, Fitness, and BMI With Heart Failure in Overweight Adults With Type 2 Diabetes

Additional Info

Association of Intensive Lifestyle Intervention, Fitness and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial

Further Reading

Effect of Insulin Type (Ultra-Rapid Vs Rapid Insulin) and Exercise Timing on Postprandial Exercise–Induced Hypoglycaemia Risk in Individuals With Type 1 Diabetes

Gastric Bypass Elicits Persistent Gut Adaptation and Unique Diabetes Remission–Related Metabolic Gene Regulation

Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in People With Diabetes and Advanced Chronic Kidney Disease

Prognostic Significance of Diabetes in Patients With NSCLC Treated With Immune Checkpoint Inhibitors

Real-World Effectiveness of Oral Semaglutide in Adults and Older Individuals With Type 2 Diabetes

Effect of Combined Use of SGLT2 Inhibitors and Pioglitazone on the Risk of MASH in Individuals With Type 2 Diabetes

Trends in the Incidence of Young Adult–Onset Diabetes by Diabetes Type

Implications of Continuous Ketone Monitoring in Clinical Practice

Characterizing the Effects of Using GLP-1 Receptor–Based Agonists on Body Composition

The SEAD Program Improved Clinical Outcomes in Underserved Young Adults With Type 1 Diabetes

Predicting Hypoglycemia and Hyperglycemia Risks During and After Physical Activity in Adolescents With Type 1 Diabetes

Recently Updated